The Combined Role of Cognitive, Plasma, Volumetric and EEG Markers Along the Alzheimer's Disease Continuum in Down Syndrome
Journal of Intellectual Disability Research · 2026-08 · 70 (8) · 823-834
DOI: 10.1111/jir.70120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Intellectual Disability Research, online erschienen am 15.05.2026. Verfasst von Javier García-Alba und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology in Education and Research, Complutense University of Madrid, Madrid, Spain. Hauptthemen laut MEDLINE: Down Syndrome, Alzheimer Disease, tau Proteins. Die Arbeit nennt 56 Literaturangaben. Gefördert von: Ministerio de Ciencia e Innovación de España.
Themen: Demenz
Abstract (Originalsprache)
Background
The validation of noninvasive markers for the early detection of Alzheimer's disease (AD) in Down syndrome (DS) is a crucial goal within this population. DS patients are characterised by their overall vulnerability and, particularly, by their high risk of developing AD due to genetic conditions. Considering this background, in this study, we analysed the benefits that a combination of markers might yield in such detection.
Methods
Sixty‐two participants (35 females, 27 males) with DS (age > 45 years) distributed in three groups (asymptomatic [A DS ], prodromal [P DS ] and dementia [D DS ]) underwent clinical and neuropsychological evaluation, together with the assessment of brain volumetry, plasma (neurofilament light and p‐tau217), genetic (APOE4) and EEG markers.
Results
Regression analyses demonstrated the key role of p‐tau217 among the studied biomarkers. However, the inclusion of p‐tau217 failed to produce any significant improvement in the diagnostic model based on verbal memory tasks. This model correctly classified 88.0% of the A DS patients, 75.0% of the P DS patients and 93.8% of the D DS patients. In addition, a strong correlation was observed between p‐tau217 , delta power, volumetric scores and memory performance.
Conclusions
Our findings suggested that, even when controlling the effect of elevated p‐tau217 levels, the role of memory markers is essential to assist in AD diagnosis within the DS population. The combination of cognitive and plasma markers for the detection of prodromal AD cases in DS appeared to be highly effective. This is especially relevant after the recent FDA's approval of plasma markers such as ptau‐217 for the diagnosis of AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychology in Education and Research, Complutense University of Madrid, Madrid, Spain.
- Center for Cognitive and Computational Neuroscience (c3n), Cognitive Neuroscience Research Group, Madrid, Spain.
- Department of Statistics and Operational Research, Complutense University of Madrid, Madrid, Spain.
- Research Group in Digital Culture and Social Movements & Department of Experimental Psychology, Cognitive Processes and Speech Therapy, Complutense University of Madrid, Madrid, Spain.
- Music and Audio Research Lab (MARL) & Center for Language Music and Emotion (CLaME), New York University, New York City, New York, USA.
- Institute of Applied Magnetism, Complutense University of Madrid, Madrid, Spain.
ORCID-Profile: Javier García-Alba, Elisa M Molanes-López
Förderung
- Ministerio de Ciencia e Innovación de España
Zitieren
APA
García-Alba, J., Molanes-López, E. M., Zuluaga, P., Vaquero, L., Bajo, R., Hinojosa, J. A., Calvillo-Torres, R., Galván-Román, J. M., Bell-Fenellos, C., Alcolea, D., Fortea, J., Lagunas, N., Alfayate, E., García, F., Mateo, G., Modenhauer, F., & Fernández, A. (2026). The Combined Role of Cognitive, Plasma, Volumetric and EEG Markers Along the Alzheimer's Disease Continuum in Down Syndrome. Journal of Intellectual Disability Research, 70(8), 823-834. https://doi.org/10.1111/jir.70120
Vancouver
García-Alba J, Molanes-López EM, Zuluaga P, Vaquero L, Bajo R, Hinojosa JA, et al. The Combined Role of Cognitive, Plasma, Volumetric and EEG Markers Along the Alzheimer's Disease Continuum in Down Syndrome. Journal of Intellectual Disability Research. 2026;70(8):823-834. doi:10.1111/jir.70120
BibTeX
@article{GarcaAlba2026,
author = {García-Alba, Javier and Molanes-López, Elisa M and Zuluaga, Pilar and Vaquero, Lucía and Bajo, Ricardo and Hinojosa, José A and Calvillo-Torres, Rocío and Galván-Román, José M and Bell-Fenellos, Cristina and Alcolea, Daniel and Fortea, Juan and Lagunas, Natalia and Alfayate, Eva and García, Felipe and Mateo, Gloria and Modenhauer, Fernando and Fernández, Alberto},
title = {The Combined Role of Cognitive, Plasma, Volumetric and EEG Markers Along the Alzheimer's Disease Continuum in Down Syndrome},
journal = {Journal of Intellectual Disability Research},
year = {2026},
volume = {70},
number = {8},
pages = {823--834},
doi = {10.1111/jir.70120}
}
EUVIMED